tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Actinogen Medical Advances Xanamem Trials for Alzheimer’s and Depression
Company AnnouncementsActinogen Medical Advances Xanamem Trials for Alzheimer’s and Depression
4d ago
Actinogen Medical Schedules 2025 Annual General Meeting
PremiumCompany Announcements
Actinogen Medical Schedules 2025 Annual General Meeting
4d ago
Actinogen Medical Secures $5.5 Million R&D Tax Rebate Amidst Clinical Trial Progress
PremiumCompany Announcements
Actinogen Medical Secures $5.5 Million R&D Tax Rebate Amidst Clinical Trial Progress
5d ago
Actinogen Medical Sets AGM Date and Advances Xanamem Trials
PremiumCompany Announcements
Actinogen Medical Sets AGM Date and Advances Xanamem Trials
20d ago
Actinogen Medical Announces Cessation of Securities
PremiumCompany Announcements
Actinogen Medical Announces Cessation of Securities
21d ago
Actinogen Secures FDA Agreement for Xanamem Alzheimer’s Trial
PremiumCompany AnnouncementsActinogen Secures FDA Agreement for Xanamem Alzheimer’s Trial
1M ago
Actinogen Medical Boosts Investor Engagement with New Hub
Premium
Company Announcements
Actinogen Medical Boosts Investor Engagement with New Hub
1M ago
Actinogen Medical Advances Alzheimer’s and Depression Trials
Premium
Company Announcements
Actinogen Medical Advances Alzheimer’s and Depression Trials
1M ago
Actinogen Medical Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Actinogen Medical Announces Quotation of New Securities on ASX
2M ago
Actinogen Medical Announces Cessation of Securities
PremiumCompany Announcements
Actinogen Medical Announces Cessation of Securities
2M ago
Actinogen’s Xanamem Tablet Achieves Key Trial Milestone
PremiumCompany Announcements
Actinogen’s Xanamem Tablet Achieves Key Trial Milestone
2M ago
Actinogen Medical Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Actinogen Medical Releases 2025 Corporate Governance Statement
2M ago
Actinogen Medical Reinforces Commitment to Corporate Governance
PremiumCompany AnnouncementsActinogen Medical Reinforces Commitment to Corporate Governance
2M ago
Actinogen Medical Advances Alzheimer’s Trials and Secures Funding in FY2025
Premium
Company Announcements
Actinogen Medical Advances Alzheimer’s Trials and Secures Funding in FY2025
2M ago
Actinogen Medical Reports 2025 Financial Results and Clinical Trial Progress
Premium
Company Announcements
Actinogen Medical Reports 2025 Financial Results and Clinical Trial Progress
2M ago
Actinogen Medical Highlights Alzheimer’s Trial Progress at 2025 Bioshares Summit
PremiumCompany Announcements
Actinogen Medical Highlights Alzheimer’s Trial Progress at 2025 Bioshares Summit
2M ago
Actinogen Medical Advances Alzheimer’s Trial and Secures R&D Funding
PremiumCompany Announcements
Actinogen Medical Advances Alzheimer’s Trial and Secures R&D Funding
3M ago
Actinogen Medical Validates Xanamem’s Efficacy at Alzheimer’s Conference
PremiumCompany Announcements
Actinogen Medical Validates Xanamem’s Efficacy at Alzheimer’s Conference
3M ago
Actinogen Medical Secures $13.8 Million in Non-Dilutive Funding to Advance Alzheimer’s Trial
PremiumCompany Announcements
Actinogen Medical Secures $13.8 Million in Non-Dilutive Funding to Advance Alzheimer’s Trial
4M ago
Actinogen Medical Advances Alzheimer’s Trial with Key Milestone
PremiumCompany AnnouncementsActinogen Medical Advances Alzheimer’s Trial with Key Milestone
4M ago
BVF Partners Ceases Substantial Holding in Actinogen Medical
Premium
Company Announcements
BVF Partners Ceases Substantial Holding in Actinogen Medical
5M ago
Actinogen’s Xanamem Shows Promise in Depression Treatment
Premium
Company Announcements
Actinogen’s Xanamem Shows Promise in Depression Treatment
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >